Cargando…

An update on the effect of intra-articular intervention strategies using nanomaterials in osteoarthritis: Possible clinical application

Osteoarthritis (OA) is the most common progressive condition affecting joints. It mainly affects the knees and hips as predominant weight-bearing joints. Knee osteoarthritis (KOA) accounts for a large proportion of osteoarthritis and presents numerous symptoms that impair quality of life, such as st...

Descripción completa

Detalles Bibliográficos
Autores principales: Amirsaadat, Soumayeh, Amirazad, Halimeh, Hashemihesar, Ramin, Zarghami, Nosratollah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978162/
https://www.ncbi.nlm.nih.gov/pubmed/36873347
http://dx.doi.org/10.3389/fbioe.2023.1128856
_version_ 1784899456046465024
author Amirsaadat, Soumayeh
Amirazad, Halimeh
Hashemihesar, Ramin
Zarghami, Nosratollah
author_facet Amirsaadat, Soumayeh
Amirazad, Halimeh
Hashemihesar, Ramin
Zarghami, Nosratollah
author_sort Amirsaadat, Soumayeh
collection PubMed
description Osteoarthritis (OA) is the most common progressive condition affecting joints. It mainly affects the knees and hips as predominant weight-bearing joints. Knee osteoarthritis (KOA) accounts for a large proportion of osteoarthritis and presents numerous symptoms that impair quality of life, such as stiffness, pain, dysfunction, and even deformity. For more than two decades, intra-articular (IA) treatment options for managing knee osteoarthritis have included analgesics, hyaluronic acid (HA), corticosteroids, and some unproven alternative therapies. Before effective disease-modifying treatments for knee osteoarthritis, treatments are primarily symptomatic, mainly including intra-articular corticosteroids and hyaluronic acid, so these agents represent the most frequently used class of drugs for managing knee osteoarthritis. But research suggests other factors, such as the placebo effect, have an essential role in the effectiveness of these drugs. Several novel intra-articular therapies are currently in the clinical trial processes, such as biological therapies, gene and cell therapies. Besides, it has been shown that the development of novel drug nanocarriers and delivery systems could improve the effectiveness of therapeutic agents in osteoarthritis. This review discusses the various treatment methods and delivery systems for knee osteoarthritis and the new agents that have been introduced or are in development.
format Online
Article
Text
id pubmed-9978162
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99781622023-03-03 An update on the effect of intra-articular intervention strategies using nanomaterials in osteoarthritis: Possible clinical application Amirsaadat, Soumayeh Amirazad, Halimeh Hashemihesar, Ramin Zarghami, Nosratollah Front Bioeng Biotechnol Bioengineering and Biotechnology Osteoarthritis (OA) is the most common progressive condition affecting joints. It mainly affects the knees and hips as predominant weight-bearing joints. Knee osteoarthritis (KOA) accounts for a large proportion of osteoarthritis and presents numerous symptoms that impair quality of life, such as stiffness, pain, dysfunction, and even deformity. For more than two decades, intra-articular (IA) treatment options for managing knee osteoarthritis have included analgesics, hyaluronic acid (HA), corticosteroids, and some unproven alternative therapies. Before effective disease-modifying treatments for knee osteoarthritis, treatments are primarily symptomatic, mainly including intra-articular corticosteroids and hyaluronic acid, so these agents represent the most frequently used class of drugs for managing knee osteoarthritis. But research suggests other factors, such as the placebo effect, have an essential role in the effectiveness of these drugs. Several novel intra-articular therapies are currently in the clinical trial processes, such as biological therapies, gene and cell therapies. Besides, it has been shown that the development of novel drug nanocarriers and delivery systems could improve the effectiveness of therapeutic agents in osteoarthritis. This review discusses the various treatment methods and delivery systems for knee osteoarthritis and the new agents that have been introduced or are in development. Frontiers Media S.A. 2023-02-16 /pmc/articles/PMC9978162/ /pubmed/36873347 http://dx.doi.org/10.3389/fbioe.2023.1128856 Text en Copyright © 2023 Amirsaadat, Amirazad, Hashemihesar and Zarghami. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
Amirsaadat, Soumayeh
Amirazad, Halimeh
Hashemihesar, Ramin
Zarghami, Nosratollah
An update on the effect of intra-articular intervention strategies using nanomaterials in osteoarthritis: Possible clinical application
title An update on the effect of intra-articular intervention strategies using nanomaterials in osteoarthritis: Possible clinical application
title_full An update on the effect of intra-articular intervention strategies using nanomaterials in osteoarthritis: Possible clinical application
title_fullStr An update on the effect of intra-articular intervention strategies using nanomaterials in osteoarthritis: Possible clinical application
title_full_unstemmed An update on the effect of intra-articular intervention strategies using nanomaterials in osteoarthritis: Possible clinical application
title_short An update on the effect of intra-articular intervention strategies using nanomaterials in osteoarthritis: Possible clinical application
title_sort update on the effect of intra-articular intervention strategies using nanomaterials in osteoarthritis: possible clinical application
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978162/
https://www.ncbi.nlm.nih.gov/pubmed/36873347
http://dx.doi.org/10.3389/fbioe.2023.1128856
work_keys_str_mv AT amirsaadatsoumayeh anupdateontheeffectofintraarticularinterventionstrategiesusingnanomaterialsinosteoarthritispossibleclinicalapplication
AT amirazadhalimeh anupdateontheeffectofintraarticularinterventionstrategiesusingnanomaterialsinosteoarthritispossibleclinicalapplication
AT hashemihesarramin anupdateontheeffectofintraarticularinterventionstrategiesusingnanomaterialsinosteoarthritispossibleclinicalapplication
AT zarghaminosratollah anupdateontheeffectofintraarticularinterventionstrategiesusingnanomaterialsinosteoarthritispossibleclinicalapplication
AT amirsaadatsoumayeh updateontheeffectofintraarticularinterventionstrategiesusingnanomaterialsinosteoarthritispossibleclinicalapplication
AT amirazadhalimeh updateontheeffectofintraarticularinterventionstrategiesusingnanomaterialsinosteoarthritispossibleclinicalapplication
AT hashemihesarramin updateontheeffectofintraarticularinterventionstrategiesusingnanomaterialsinosteoarthritispossibleclinicalapplication
AT zarghaminosratollah updateontheeffectofintraarticularinterventionstrategiesusingnanomaterialsinosteoarthritispossibleclinicalapplication